title: Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D)J recombination and result in primary immunodeficiencies.
abstract: The V(D)J recombination reaction is composed of multiple nucleolytic processing steps mediated by the recombination-activating proteins RAG1 and RAG2. Sequence analysis has suggested that RAG2 contains six kelch repeat motifs that are predicted to form a six-bladed beta-propeller structure, with the second beta-strand of each repeat demonstrating marked conservation both within and between kelch repeat-containing proteins. Here we demonstrate that mutations G95R and DeltaI273 within the predicted second beta-strand of repeats 2 and 5 of RAG2 lead to immunodeficiency in patients P1 and P2. Green fluorescent protein fusions with the mutant proteins reveal appropriate localization to the nucleus. However, both mutations reduce the capacity of RAG2 to interact with RAG1 and block recombination signal cleavage, therefore implicating a defect in the early steps of the recombination reaction as the basis of the clinical phenotype. The present experiments, performed with an extensive panel of site-directed mutations within each of the six kelch motifs, further support the critical role of both hydrophobic and glycine-rich regions within the second beta-strand for RAG1-RAG2 interaction and recombination signal recognition and cleavage. In contrast, multiple mutations within the variable-loop regions of the kelch repeats had either mild or no effects on RAG1-RAG2 interaction and hence on the ability to mediate recombination. In all, the data demonstrate a critical role of the RAG2 kelch repeats for V(D)J recombination and highlight the importance of the conserved elements of the kelch motif.
authors.affiliation: Ruttenberg Cancer Center, Mount Sinai School of Medicine of New York University, New York, New York 10029, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Gomez
authors.forename: L M
authors.initials: LM
authors.lastname: Ptaszek
authors.forename: A
authors.initials: A
authors.lastname: Villa
authors.forename: F
authors.initials: F
authors.lastname: Bozzi
authors.forename: C
authors.initials: C
authors.lastname: Sobacchi
authors.forename: E G
authors.initials: EG
authors.lastname: Brooks
authors.forename: L D
authors.initials: LD
authors.lastname: Notarangelo
authors.forename: E
authors.initials: E
authors.lastname: Spanopoulou
authors.forename: Z Q
authors.initials: ZQ
authors.lastname: Pan
authors.forename: P
authors.initials: P
authors.lastname: Vezzoni
authors.forename: P
authors.initials: P
authors.lastname: Cortes
authors.forename: S
authors.initials: S
authors.lastname: Santagata
mesh_terms: D000595:Amino Acid Sequence; D002460:Cell Line; D002467:Cell Nucleus / Q000235:genetics; D017124:Conserved Sequence; D004268:DNA-Binding Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000235:genetics*; D007223:Infant; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation; D009687:Nuclear Proteins; D011487:Protein Conformation; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D011995:Recombination, Genetic; D020449:Repetitive Sequences, Amino Acid
chemical_list: D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; C499311:RAG2 protein, human; D011994:Recombinant Proteins; C064655:V(D)J recombination activating protein 2